Source: The Journal of Clinical Endocrinology & Metabolism. Unidade: FMRP
Subjects: HIPERPLASIAS, DIAGNÓSTICO PRÉ-NATAL, DOENÇAS GENÉTICAS, HORMÔNIOS GLICOCORTICOIDES, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Margaret de e MARTINS, Clarissa Silva e ANTONINI, Sonir Roberto Rauber. Prenatal dexamethasone treatment of congenital adrenal hyperplasia: are we any closer to considering it safe?. The Journal of Clinical Endocrinology & Metabolism, v. 108, n. 1, p. e9-e10, 2023Tradução . . Disponível em: https://doi.org/10.1210/clinem/dgac524. Acesso em: 31 mar. 2026.APA
Castro, M. de, Martins, C. S., & Antonini, S. R. R. (2023). Prenatal dexamethasone treatment of congenital adrenal hyperplasia: are we any closer to considering it safe? The Journal of Clinical Endocrinology & Metabolism, 108( 1), e9-e10. doi:10.1210/clinem/dgac524NLM
Castro M de, Martins CS, Antonini SRR. Prenatal dexamethasone treatment of congenital adrenal hyperplasia: are we any closer to considering it safe? [Internet]. The Journal of Clinical Endocrinology & Metabolism. 2023 ; 108( 1): e9-e10.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1210/clinem/dgac524Vancouver
Castro M de, Martins CS, Antonini SRR. Prenatal dexamethasone treatment of congenital adrenal hyperplasia: are we any closer to considering it safe? [Internet]. The Journal of Clinical Endocrinology & Metabolism. 2023 ; 108( 1): e9-e10.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1210/clinem/dgac524
